Germline BRCA1/2 Mutation Prevalence in Unselected ER-Low/HER2-Negative Breast Cancer. Yoo JW, Byeon J, Park WK, Kim J, et al. Ann Surg Oncol 2025 Nov 14. doi: 10.1245/s10434-025-18713.

Read + Share

Amedeo Smart

Independent Medical Education

Yoo JW, Byeon J, Park WK, Kim J, et al. Germline BRCA1/2 Mutation Prevalence in Unselected ER-Low/HER2-Negative Breast Cancer. Ann Surg Oncol 2025 Nov 14. doi: 10.1245/s10434-025-18713.
PMID: 41238982